Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the ...

What science says so far about which cancers can be beat by vaccines — and which will require more creative approaches.

President Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time for seniors' Medicare Part B premiums ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.

Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...

Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.

Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing ...

Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.

With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of ...

Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.